Is Llama 3 HIPAA Compliant?

What healthcare organizations need to know about Meta's open-weight model, BAA availability, and where compliance responsibility falls.

Is Llama 3 HIPAA compliant? The short answer is: it depends entirely on how and where you deploy it. Llama 3 is an open-weight model released by Meta AI — meaning Meta publishes the model weights for others to download, fine-tune, and host. Unlike a closed SaaS product with a single vendor relationship, Llama 3 has no single compliance posture. Your HIPAA obligations shift based on your deployment path, your infrastructure provider, and the business associate agreements you put in place.

This guide walks through the realistic compliance options for healthcare organizations evaluating Llama 3 in 2026: self-hosted deployments, managed cloud platforms, and the hosted Meta AI consumer product. We cover what a BAA covers, what it does not, and the safeguards your team must implement regardless of which path you choose. Always verify current certification status and BAA availability directly on Meta's official trust center before making compliance decisions.

Llama 3 Is an Open-Weight Model — Not a Single Product

Understanding Llama 3's compliance story starts with understanding what it actually is. Meta releases Llama 3 model weights under a custom community license, allowing any organization to download, modify, and deploy the model on its own infrastructure. This is fundamentally different from using a hosted AI service like ChatGPT or Claude, where the vendor controls the entire stack.

Because Llama 3 is open-weight, there is no single 'Llama 3 product' with a uniform HIPAA posture. The model itself is software — a set of mathematical weights. HIPAA compliance is a property of the system you build around it, not of the weights themselves.

Healthcare organizations typically access Llama 3 in one of three ways: self-hosting on their own servers or private cloud, deploying through a managed AI platform (AWS Bedrock, Azure AI, Google Cloud Vertex AI, or similar), or using Meta AI's consumer-facing chat product (meta.ai). Each path has a completely different compliance profile.

Meta's community license for Llama 3 restricts commercial use for organizations with more than 700 million monthly active users — but for most healthcare SMBs, the more pressing constraint is HIPAA, not licensing. Confirm your use-case licensing at ai.meta.com/llama before proceeding.
Sources
Meta AI Engineering Blog

Which Deployment Paths Support a BAA for Llama 3?

A Business Associate Agreement is the contractual foundation of HIPAA-compliant AI use. Without a signed BAA with every vendor who may access or process PHI on your behalf, you are exposed — regardless of how good your internal controls are.

For Llama 3 specifically, BAA availability breaks down by deployment path. Self-hosting on infrastructure you fully control means there is no third-party vendor to sign a BAA for the model layer — you own the risk entirely. Your cloud infrastructure provider (AWS, Azure, GCP) may offer a BAA for the underlying compute, but the AI model layer is your responsibility to secure and validate.

Managed platforms that host Llama 3 as an API — such as AWS Bedrock or Azure AI Studio — may include Llama 3 in their HIPAA-eligible service offerings, and those vendors do offer BAAs. However, eligibility on a platform does not automatically mean PHI is safe; you must configure the service correctly and understand what data the platform logs, retains, or uses for training. Always check the specific service's current HIPAA eligibility status on the vendor's trust center, because model availability in HIPAA-eligible tiers changes.

  • Self-hosted Llama 3: No vendor BAA needed for the model layer; your infrastructure BAA with AWS/Azure/GCP covers the compute only.
  • AWS Bedrock (Llama 3 hosted): AWS offers a BAA; verify Llama 3 is currently listed as a HIPAA-eligible service at aws.amazon.com/compliance/hipaa-eligible-services-reference.
  • Azure AI Studio (Llama 3 hosted): Microsoft offers a BAA for Azure services; confirm Llama 3 model deployments are in scope at Microsoft's Trust Center.
  • Google Cloud Vertex AI (Llama 3 hosted): Google offers a BAA for eligible services; verify current Llama 3 status at cloud.google.com/security/compliance/hipaa.
  • Meta AI consumer product (meta.ai): No BAA is available. Do not use PHI with Meta's consumer chat interface.
As of mid-2026, Meta does not offer a BAA for its consumer-facing Meta AI product. If your clinicians are pasting patient information into meta.ai, that is a HIPAA violation — regardless of any other controls you have in place.

What Meta AI Does Not Cover — and Why That Matters

Because Llama 3 is an open-weight model, Meta's direct compliance responsibilities are narrower than you might expect from a typical AI SaaS vendor. Meta is not your business associate in a self-hosted deployment — it never processes your patients' data. The compliance surface belongs entirely to your organization and your infrastructure vendors.

When you use Llama 3 through a managed cloud platform, Meta is still not your business associate; the platform provider is. Meta's role is essentially that of a software licensor. This is an important distinction for your compliance officer and legal counsel to understand, because it means there is no Meta trust center configuration, no Meta HIPAA mode to enable, and no Meta audit log to pull.

For the consumer Meta AI product, the situation is more direct: Meta's privacy policy governs data handling, it does not include healthcare-grade protections, and there is no mechanism to sign a BAA with Meta for that product. The consumer product is not appropriate for any PHI under any configuration.

The open-weight distribution model shifts more compliance responsibility to the deploying organization than most healthcare IT teams are used to. Budget time for a formal risk analysis under 45 CFR § 164.308(a)(1) before any clinical deployment.

Safeguards Your Organization Must Implement Regardless of Deployment Path

A BAA from your cloud provider is a necessary but not sufficient condition for HIPAA compliance. The Security Rule requires administrative, physical, and technical safeguards that your team must design and maintain — the vendor's BAA does not build those for you.

For any Llama 3 deployment touching PHI, your organization needs a documented risk analysis specific to the AI system, access controls that limit which staff can submit PHI to the model, audit logging of queries and outputs that contain PHI, data minimization practices to strip or de-identify PHI before it enters the model where possible, and a clear retention and deletion policy for any PHI stored in prompt histories or fine-tuning datasets.

Fine-tuning Llama 3 on clinical data deserves special attention. The model weights trained on PHI become a data asset subject to the Privacy and Security Rules. Many organizations have not thought through the implications of a fine-tuned model as a PHI-bearing artifact — including who can access the weights, where they are stored, and how they are disposed of at end of life.

  • Conduct a written risk analysis under 45 CFR § 164.308(a)(1) covering the AI deployment specifically.
  • Implement role-based access controls on any API endpoint or UI that submits queries to the model.
  • Enable and retain audit logs at the infrastructure and application layers — both must cover PHI data flows.
  • Apply de-identification (Safe Harbor or Expert Determination) before using patient data in prompts when clinically feasible.
  • Treat fine-tuned model weights containing PHI as a PHI-bearing asset: encrypt at rest and in transit, restrict access, and plan for secure disposal.
  • Train staff on appropriate versus prohibited use cases before any clinical rollout.

How to Verify Llama 3 Compliance Status Before You Deploy

Compliance certifications and HIPAA-eligible service lists change. A service that was not HIPAA-eligible last year may be eligible today, and vice versa. Never rely on a blog post — including this one — as your primary source of truth on a vendor's current compliance status.

For self-hosted deployments, the primary verification step is confirming that your underlying cloud infrastructure (compute, storage, networking) is covered by your existing cloud provider BAA, and that you have documented the scope of that BAA in your risk analysis.

For managed platform deployments, go directly to the platform's trust center and HIPAA documentation page to confirm that Llama 3 (by the specific model version you intend to use) is listed as a HIPAA-eligible service. Then review the platform's shared responsibility model to understand exactly what the vendor secures versus what your team must configure. Contact the vendor's enterprise sales or compliance team if there is any ambiguity.

  • AWS: aws.amazon.com/compliance/hipaa-eligible-services-reference
  • Azure: Microsoft Trust Center at microsoft.com/en-us/trust-center
  • Google Cloud: cloud.google.com/security/compliance/hipaa
  • Meta AI (consumer product): No BAA available — not appropriate for PHI under any circumstances.
Platform HIPAA-eligible service lists are updated on a rolling basis and do not always appear in press releases. Check the list directly rather than relying on announcements or third-party summaries.

Is Llama 3 HIPAA Compliant? The Bottom Line

Llama 3 can be deployed in a HIPAA-compliant manner, but only through specific paths and only when your organization builds and maintains the required safeguards. The model's open-weight design means compliance is primarily your responsibility — not Meta's. There is no 'Llama 3 HIPAA mode' to enable, and no Meta BAA to sign for the model layer.

Self-hosted deployments give you maximum control and maximum responsibility. Managed platform deployments (AWS Bedrock, Azure AI Studio, Google Cloud Vertex AI) can simplify the BAA picture but require careful configuration and ongoing verification that Llama 3 remains in the HIPAA-eligible tier. The Meta AI consumer product is not appropriate for PHI under any circumstances.

If your healthcare organization is evaluating Llama 3 for clinical workflows, documentation automation, or other use cases involving PHI, the right first step is a formal risk analysis and a compliance review with people who understand both HIPAA and AI systems. Layer3 Labs helps healthcare SMBs navigate exactly this — from deployment architecture to BAA review to staff training.

Frequently Asked Questions

  • Llama 3 can be used in a HIPAA-compliant deployment, but it is not inherently HIPAA compliant on its own. Because it is an open-weight model, compliance depends entirely on how and where you deploy it, which infrastructure provider you use, what BAAs are in place, and what safeguards your organization implements. The Meta AI consumer product (meta.ai) is not appropriate for PHI under any circumstances. Verify current status with your infrastructure provider's trust center before deploying.
  • Meta does not offer a BAA for the Llama 3 model weights themselves, nor for the consumer Meta AI product. In a self-hosted deployment, Meta is not your business associate because it never processes your data. If you deploy Llama 3 through a managed cloud platform like AWS Bedrock or Azure AI Studio, the BAA comes from that platform provider, not from Meta. Always verify BAA scope with your platform vendor directly.
  • No. Meta's consumer-facing Meta AI product does not support a BAA and is not designed for healthcare data. Inputting any PHI into meta.ai would constitute a HIPAA violation. If clinicians at your organization are using meta.ai for clinical tasks, that is an immediate compliance risk that requires policy intervention and staff training.
  • AWS Bedrock, Azure AI Studio, and Google Cloud Vertex AI each offer BAAs and maintain HIPAA-eligible service programs that may include Llama 3. However, model availability within HIPAA-eligible tiers changes, so you must verify that the specific Llama 3 version you intend to use is currently listed as eligible on each platform's official compliance documentation. A BAA alone is not sufficient — you also need proper configuration and access controls on your end.
  • Fine-tuned model weights trained on PHI become a PHI-bearing asset subject to the HIPAA Security Rule. That means the weights must be encrypted at rest and in transit, access must be restricted to authorized personnel, the fine-tuning process must be covered by your risk analysis, and you need a secure disposal plan for when those weights are retired. Many organizations overlook this — treating fine-tuned weights like any other software artifact rather than a data asset containing patient information.
  • No. A BAA from your cloud provider is a necessary starting point, but HIPAA compliance also requires administrative, physical, and technical safeguards under the Security Rule. You need a documented risk analysis specific to the AI deployment, role-based access controls, audit logging, data minimization practices, workforce training, and more. The vendor's BAA establishes their obligations — it does not build or validate your organization's controls.
  • ChatGPT (OpenAI) and Claude (Anthropic) are closed, hosted services where the vendor controls the entire stack and can sign a BAA directly for the API. Llama 3 is an open-weight model where Meta publishes the weights and you (or a cloud platform) run the infrastructure. This means the BAA and compliance responsibility landscape is more complex for Llama 3 — you have more flexibility but also more direct responsibility. For a detailed comparison, see our AI Model Compliance Comparison guide.

Not Sure If Your Llama 3 Deployment Is Truly HIPAA Compliant?

Book a free 30-minute AI compliance review with Layer3 Labs. We help healthcare organizations map their AI deployment architecture, identify BAA gaps, and build the safeguards the Security Rule actually requires — before a breach or audit forces the issue.

Book Your Free Compliance Review